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ABSTRACT
The checkpoint protein Rad9/Rad1/Hus1 heterotri-
mer (the 9-1-1 complex) is structurally similar to the
proliferating cell nuclear antigen sliding clamp and
has been proposed to sense DNA damage that
leads to cell cycle arrest or apoptosis. Human (h)
NEIL1 DNA glycosylase, an ortholog of bacterial
Nei/Fpg, is involved in repairing oxidatively
damaged DNA bases. In this study, we show that
hNEIL1 interacts with hRad9, hRad1 and hHus1 as
individual proteins and as a complex. Residues 290–
350 of hNEIL1 are important for the 9-1-1 associa-
tion. A significant fraction of the hNEIL1 nuclear foci
co-localize with hRad9 foci in hydrogen peroxide
treated cells. Human NEIL1 DNA glycosylase activ-
ity is significantly stimulated by hHus1, hRad1,
hRad9 separately and the 9-1-1 complex. Thus, the
9-1-1 complex at the lesion sites serves as both a
damage sensor to activate checkpoint control and a
component of base excision repair.
INTRODUCTION
The eukaryotic genome is vulnerable to an array of
DNA damaging agents of both endogenous and environ-
mental origin. Reactive oxygen species (ROS)
are commonly generated as by-products during mitochon-
drial oxidative phosphorylation, during inﬂammatory
responses, and from exposure to ionizing radiation and
various chemicals. Eﬀects of ROS are believed to
contribute to degenerative diseases such as aging, cancer
and cardiovascular disease. The DNA damage induced by
ROS includes strand breaks and oxidative base lesions
that are typically repaired by the base excision repair
(BER) pathway (1,2). The ﬁrst step in BER is carried
out by a lesion-speciﬁc DNA glycosylase, which cleaves
the N-glycosidic bond between a base and deoxyribose.
Using a base-ﬂipping mechanism, glycosylases ﬁnd
lesions in the vast genomic DNA, and excise the damaged
bases to generate toxic and mutagenic apurinic/apyrimi-
dinic (AP) sites (3). Bifunctional glycosylases also possess
an intrinsic AP-lyase (b-o rb/d-elimination) activity
which cleaves 50-phosphodiester bond (b lyase) or both
50 and 30 phosphodiester bonds (b/d lyase) of the AP site.
Escherichia coli Nei (Endo VIII) and Fpg (MutM),
are prototypes of DNA glycosylases with b- and b/d-
elimination activities, respectively (4).
Mammalian homologs of E. coli Nei and Fpg have been
identiﬁed and named Nei-like glycosylases (NEILs) (5–9).
NEIL glycosylases containing b/d-elimination activities
excise a broad range of oxidatively damaged bases,
including 5-hydroxyuracil (5-OHU), thymine glycol
(Tg), uracil, 8-oxoguanine (8-oxoG) and ring-fragmented
purines. The substrate speciﬁcities of NEIL1 and NEIL2
overlap with those of OGG1 (a functional homolog of
E. coli Fpg) and NTH1 (a homolog of E. coli Endo III).
However, NEILs have preference for single-stranded
DNA, suggesting their roles in repairing transcribed or
replicating DNA sequences (10). NEIL1-depleted cells
show enhanced radiation sensitivity (11) in contrast to
OGG1- and NTH1-null cells, which exhibit no increase in
sensitivity to ROS and radiation (12,13). Inactivating
mutations in the hNEIL1 gene is associated with gastric
cancer (14). The neil1 knockout mice develop the
metabolic syndrome with symptoms such as severe
obesity, dyslipidemia, and fatty liver disease (15).
DNA repair is coordinated with cell-cycle progression
and DNA-damage checkpoints (16,17). Checkpoints are
activated upon DNA damage in order to arrest cell cycle
progression and to enhance DNA repair or to induce
apoptosis with excessive DNA damage. The loss of proper
response to DNA damage can lead to genomic instability,
and has been implicated in carcinogenesis. This activation
requires the action of DNA-damage sensors and transduc-
ers, and eﬀectors (18). Among these, Rad9, Rad1 and
Hus1 form a heterotrimeric complex (the 9-1-1 complex)
that exhibits structural similarity with the homotrimeric
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(19–21). The 9-1-1 complex is loaded onto DNA by an
alternative clamp loader Rad17/RFC2-5 (22–24).
Moreover, the 9-1-1 complex, Rad17/RFC2-5 and
PCNA co-localize in foci formed upon DNA damage
(25,26). These data suggest a mechanism in which Rad17/
RFC2-5 localizes to DNA lesions, allowing the recruit-
ment of the 9-1-1 complex to these sites. Subsequently, the
9-1-1 complex serves as a recruitment platform for the
checkpoint eﬀector kinases such as Chk1 or Chk2, which
are subsequently phosphorylated by ataxia telangiectasia
mutated protein (ATM) or ATR (ATM- and Rad3-related
protein). Additionally, a model has recently been pro-
posed by two diﬀerent groups, where the 9-1-1 complex
and the Rad17/RFC2-5 clamp loader could stabilize
stalled replication forks (23,27).
The link between checkpoint activation and recruitment
of repair machineries to DNA lesions has been
demonstrated through interaction and co-localization of
checkpoint sensors with proteins involved in various
DNA-repair processes upon DNA damage (26,28,29).
However, the mechanism by which the sensor checkpoint
proteins detect diﬀerent types of DNA lesions remains
elusive. It has been suggested that the checkpoint proteins
may detect a common intermediate, such as single-
stranded DNA coated by replication protein A (RPA)
(30). RPA has been shown to directly interact with the
9-1-1 complex (31). Recently, several reports support a
hypothesis that checkpoint proteins may require a series of
‘adaptors’ to recognize DNA damage (28,32–34). Such
adaptor proteins may be DNA damage recognition
proteins involved in mismatch repair, nucleotide excision
repair, BER, and double-strand break repair.
Recent investigations have established a link between
the human 9-1-1 complex and the BER pathway. We have
shown that the 9-1-1 complex physically and functionally
interacts with the MutY homologs (MYHs) of
Schizosaccharomyces pombe and human (35,36). In addi-
tion, Hus1 phosphorylation is dependent on MYH
expression in S. pombe (35). The 9-1-1 complex has been
shown to interact with and stimulate other BER enzymes,
which include polymerase b (Polb) (37), ﬂap endonuclease
1 (FEN1) (38,39), and DNA ligase l (40,41). In the present
report, we demonstrate that hNEIL1 DNA glycosylase
physically and functionally interacts with Rad9, Rad1 and
Hus1 as individual proteins and as a complex. The
interacting site of the 9-1-1 complex is localized to the
C-terminal domain of hNEIL1. Our results strongly
suggest that the 9-1-1 complex not only serves as
a damage sensor to activate checkpoint control, but it is
also a component of the BER pathway and may provide a
platform for diﬀerent factors involved in BER.
MATERIALS AND METHODS
Humancell culture
Human HeLa S3 and 293 cell lines were purchased from
American Type Cell Culture (ATCC). HeLa cells were
cultured in modiﬁed Ham’s F-12 (Mediatech, Herndon,
VA, USA) supplemented with 10% fetal bovine serum
(FBS). The 293 cells were cultured in Dulbecco’s modiﬁed
Eagle medium (DMEM) supplemented with 10% FBS. At
90% conﬂuence, cells were transfected with pFLAG-
NEIL1 (see below) using Fugene6 (Roche, Nutley, NJ,
USA). The cells were replanted at 24h after the
transfection. Cell extracts were prepared as described
(42,43). The protein concentration was determined by
Bio-Rad’s protein assay (Bio-Rad, Hercules, CA, USA).
Construction of expression plasmids pFLAG-NEIL1
To generate the FLAG-tagged NEIL1 expression con-
struct, hNEIL1 cDNA encoded residues 1-390 was
polymerase chain reaction (PCR) ampliﬁed with primers
hNEIL1-50-EcoRI and hNEIL1-30-XbaI (listed in Table
S1 in the supplementary data) using template pRESETB-
hNEIL1 (8). The PCR products were digested with EcoRI
and XbaI, then ligated into EcoRI and XbaI digested
pFLAG-CMV 5.1 (Sigma, St. Louis, MO, USA) vector
for expression of C-terminal FLAG-tagged NEIL1. The
cloned NEIL1 gene sequence was conﬁrmed by DNA
sequencing using CMV30 and CMV24 (Sigma) sequencing
primers.
Construction of expression plasmids forglutathione-S-
transferase (GST)-fusions andHis-hNEIL1 proteininE.coli
The full-length cDNA encoded residues 1–390 of hNEIL1
was ampliﬁed by PCR method by Pfu DNA polymerase
using the primers hNEIL1-F and hNEIL1-R (listed in
Table S1 in the supplementary data), and template
pFLAG-NEIL1. The PCR products were digested
with BglII and XhoI and ligated into the BamHI-XhoI-
digested pGEX-4T-2 vector (GE Health, Princeton NJ,
USA) and pET-21a vector (EMD Biosciences, San Diego,
CA, USA) to yield plasmids pGEX-NEIL1 and pET-
NEIL1, respectively. The sequences of the cloned genes
were conﬁrmed by DNA sequencing. The plasmids
pGEX-3X-hHus1 (hHus1 coding region inserted at
BamHI and XhoI sites) and pGEX-4T3-hRad9 (hRad9
coding region inserted at BamHI and EcoRI sites),
which contained GST-tagged hHus1 and hRad9, respec-
tively, were obtained from Dr A. E. Tomkinson
(University of Maryland, Baltimore, MD, USA).
The pGEX-3X-hRad1 plasmid (Rad1 coding region
inserted at BamHI and EcoRI sites) was obtained from
Dr E. Y. Lee (University of California, Irvine, CA, USA)
through Dr A. E. Tomkinson.
Construction and expression of hRad9,hRad1 and hHus1
in E. coli
The cDNA of hHus1, hRad1 and hRad9 were ampliﬁed
by PCR from GST-Rad9, GST-Rad1 and GST-Hus1
plasmids. The sequences of forward and reverse primers
for these PCR reactions are given in Table S1 in the
supplementary data. The hHus1 gene was cloned between
the BamH1 and Not1 sites of pET-21a (EMD Biosciences)
to obtain the clone pET21a-hHus1 as described (36). The
hRad9 gene was cloned between the BglII and XhoI sites
of pACYCDuet-1 (EMD Biosciences) to obtain the clone
pACYCD-hRad9. The hRad1 gene was cloned between
the BamH1 and SalI sites of pACYCD-hRad9 to obtain
2464 Nucleic Acids Research, 2007, Vol. 35, No. 8pACYCD-hRad1-hRad9. The hHus1, hRad1, and hRad9
proteins were tagged with a C-terminal His, N-terminal
His, and C-terminal S-tag, respectively.
The BL21 Star cells (Stratagene, La Jolla, CA, USA)
harbouring the expression plasmids, pET21a-hHus1
and pACYCD-hRad1-hRad9, were cultured in LB
broth containing 100mg/ml of ampicillin and 50mg/ml
of chloramphenical at 378C. Protein expression was
induced at an A590 of 0.6 by the addition of iso-
propylthiogalactoside (IPTG) to a ﬁnal concentration of
0.2mM and the cells were grown at 208C and then
harvested 16h later.
Expression andpurification of hRad9, hRad1,hHus1 and the
9-1-1 complex inbaculovirus system
The Sf9 insect cells (Invitrogen, Princeton, NJ, USA)
were grown in 80ml of Sf-900 II SFM complete
medium (GIBCO/BRL) in suspension to 3 10
6cells/ml
and then infected with baculovirus vectors containing
cDNA encoding FLAG-hRad9 (obtained from Dr Alan
Tomkinson), FLAG-hRad1(obtained from Dr Aziz
Sancar), or FLAG-hHus1 (obtained from Dr Aziz
Sancar) and supplemented with 0.2% FBS. For expression
of the 9-1-1 complex, 500ml culture of the Sf9 insect cells
were coinfected with a mixture of three viruses carrying
cDNA encoding hRad9, hRad1 and hHus1. About 48h
after infection, the cells were harvested by centrifuge at
1500 g for 2min. The cell pellets were lysed in 10 packed
cell volumes of lysis buﬀer [(50mM Tris-HCl, pH 7.5,
0.5% Nonidet P-40, 0.3M NaCl, and 0.1mM phenyl-
methylsulfonyl ﬂuoride (PMSF)] and incubated on ice for
15min before centrifuged for 30min at 32000 g. The
supernatants were incubated with 1ml (for the 9-1-1
complex) or 0.5ml (for each subunit) of 50% slurry of
Anti-FLAG M2 Aﬃnity Gel (Sigma) at 48C overnight.
The resin was then washed four times with lysis buﬀer and
the proteins were eluted with 1ml (for h9-1-1 complex) or
0.45ml (for each subunit) elution buﬀer [50mM Tris–HCl,
pH 7.5, 0.05% Nonidet P-40, 0.3M NaCl, 0.1mM PMSF
and 200mg/ml FLAG peptide (Sigma)]. FLAG-hRad9,
FLAG-hRad1 and FLAG-hHus1 were dialysed against
lysis buﬀer without Nonidet P-40 and stored at  808C.
The 9-1-1 complex was further puriﬁed by a Sepharose-12
gel ﬁltration column (GE Health) with a buﬀer containing
20mM KPO4, pH 7.4, 0.1mM EDTA, 0.2M KCl, 10%
glycerol, 0.5mM dithiothreitol (DTT), 0.1mM PMSF.
The column was run at 0.25ml/min and 0.25ml fractions
were collected. By comparison to the size markers (bovine
thyroglobin, apoferritin, b-amylase, and bovine serum
albumin), the 9-1-1 complex eluted in a position corre-
sponding to a mass of about 120kDa, which is in line with
the theoretical value (110kDa) of a trimeric complex. The
samples were divided into small aliquots and stored at
 808C. The protein concentration was determined by the
Bradford method (44).
The human 9-1-1 complex expressed in the baculovirus
system used in the initial experiments was kindly provided
by Dr Howard Lieberman (Columbia University).
Otherproteins used
Untagged hNEIL1 and deletion constructs were puriﬁed
as described (8,45). His-tagged hNEIL1 was puriﬁed from
E. coli BL21 Star cells (Stratagene) that harbour the
expression plasmid pET-NEIL1 by Ni-NTA resin
(QIAGEN, Valencia, CA, USA) and then by 1ml Hi-
Trap Q and SP columns (GE Health) as described (8,45).
Human His-tagged hHus1 expressed in E. coli BL21 Star
cells (Stratagene) was puriﬁed by Ni-NTA resin
(QIAGEN) and 1ml Heparin column (GE Health)
as described (36). The human 9-1-1 complex expressed in
E. coli BL21 Star cells was partially puriﬁed by Ni-NTA
resin (QIAGEN) harboring the expression plasmids,
pET21a-hHus1 and pACYCD-hRad1-hRad9.
GST pull-down assay
The BL21 Star cells (Stratagene) harbouring the GST
expression plasmids were cultured in LB broth containing
100mg/ml of ampicillin. Protein expression was induced as
described above. The cell paste, from a 500ml culture, was
resuspended in 9ml of buﬀer G (50mM Tris–HCl, pH 7.4,
150mM NaCl and 2mM EDTA) containing 0.5mM DTT
and 0.1mM PMSF and treated with lysozyme (1mg/ml)
for 30min at 48C. After sonication, the solution was
centrifuged at 10000 g for 20min and the supernatant
was saved. The GST-tagged proteins were immobilized on
glutathione-sepharose 4B (GE Health) as described (43).
GST fusion proteins (500ng) were incubated with puriﬁed
protein or cell extracts in 0.2ml volume at 48C with
shaking overnight. After centrifugation at 1000 g for
2min, the pellets were washed ﬁve times with 1ml of
buﬀer G containing Nonidel P-40. Bound proteins were
eluted by boiling in SDS loading buﬀer [30mM Tris-HCl,
pH 6.8, 5% (v/v) glycerol, 1% SDS, 0.5mg/ml bromo-
phenol blue and 1% b-mercapoethanol] and resolved on a
12% SDS polyacrylamide gel. The proteins were subse-
quently analysed by western blot using the corresponding
antibodies according to established methods.
Ni-affinity binding
His-Select (Sigma) magnetic beads (20ml suspension) were
washed once with water, equilibrated with binding buﬀer
(50mM Tris–HCl, pH 7.5, 200mM NaCl, 10mM
imidazole), and then incubated with His-tagged hHus1
(500ng) in binding buﬀer for 1h at 48C with gentle
rocking. The beads were then pelleted using a magnetic
separator and washed three times with binding buﬀer then
equilibrated with interaction buﬀer (50mM Tris–HCl, pH
7.5, 400mM NaCl, 10mM imidazole). Wild-type and
mutant hNEIL1 (250ng) in interaction buﬀer were
incubated with the beads for 2h at 48C with gently
rocking. Again the beads were pelleted on a magnetic
separator and washed three times with ﬁnal wash buﬀer
(50mM Tris–HCl, pH 7.5, 500mM NaCl, 10mM
imidazole). The NEIL1/Hus1 complex was eluted with
20ml of SDS loading buﬀer and resolved on a 12% SDS
polyacrylamide gel. The presence of NEIL1 was examined
by western analysis with anti-NEIL1 antibody.
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Wild-type and mutant hNEIL1 were separated by 10%
SDS-PAGE and transferred to nitrocellulose membrane.
The membrane was washed with 1  PBS and treated with
6M guanidine-HCL in PBS for 10min at 48C. The
proteins were then renatured with serial dilutions of
guanidine-HCL in PBS, diluted by 1mM DTT in PBS at
48C to a ﬁnal concentration of 0.09M guanidine-HCL.
After blocking with 5% non-fat dry milk and Tween-20 in
PBS for 45min at 48C, the membrane was incubated with
10pmol/ml of his-tagged hHus1 in blocking solution
containing 1mM DTT and 100mM trimethylamine-N-
oxide dihydrate (TMAO) for 3h at 48C. Subsequent
western blotting was performed using anti-His-tag anti-
body followed by anti-Rabbit IgG HRP-conjugated
secondary antibody (Amersham Biosciences, Piscataway,
NJ, USA).
Co-immunoprecipitation
Extracts (1mg) derived from HeLa cells expressing
FLAG-NEIL1 were precleared by adding 30ml Protein
G agarose (Invitrogen) for 1–4h at 48C. After centrifuga-
tion at 1000 g, the supernatant was incubated with 4mg
of polyclonal anti-FLAG or anti-His (HA) overnight at
48C. Protein G agarose (30ml) was added and incubated
for 4–12h at 48C. After centrifugation at 1000 g, the
supernatant was saved and the pellet was washed. Both
the supernatant ( 10% of total volume) and pellet
fractions were resolved on a 12% SDS–PAGE and
western blot analysis for hRad9 was performed.
Westernblotting and antibodies
Proteins were separated on SDS-polyacrylamide gels and
transferred to nitrocellulose membrane. The membranes
were blocked with PBS with 0.1% Tween-20 and 10%
nonfat dry milk, reacted with primary antibodies, and then
incubated with horseradish peroxidase-linked second anti-
bodies with wash between each step (46). Western blotting
was detected by the Enhanced Chemiluminescence (ECL)
analysis system (GE Health) according to the manufac-
turer’s protocol. Human NEIL1 polyclonal antibody was
from Alpha Diagnostics. Polyclonal and monoclonal
antibodies of Rad9 are from Stratagene and Imegenex,
respectively. His-tag antibody is from BD Bioscience while
anti-FLAG and HA are from Sigma.
Immunofluorescence staining
Human HeLa cells were transiently transfected with
pFLAG-NEIL1, replanted at 24h after the transfection
in Lab-Tek chamber slides (NUNC) overnight, treated
with 5mM H2O2 for 40min, and then recovered in serum-
free media for 6h. The cells were ﬁxed with 4%
formaldehyde for 15min at room temperature, and
permeabilized at room temperature in PBS-0.1% Triton
X-100 for 10min. After being blocked in PBS containing
15% FBS for 15min at 378C, the cells were reacted with
FLAG monoclonal antibody (Sigma/Aldrich) and hRad9
polyclonal antibody (Stratagene) at 378C for 30min.
Next, the cells were washed three times for 15min each
in PBS and incubated with Alexa Fluor 594 goat anti-
rabbit and Alexa Fluro 488 goat anti-mouse antibodies
(Invitrogen) at a 1:250 dilution in PBS for 30min at 378C.
The cells were then washed three times in PBS. Nuclear
DNA was counterstained with 40,60-diamidineno-a-
phenylindole (DAPI) (Vector Laboratories, Burlingame,
CA, USA). Images were captured with a Nikon E400
ﬂuorescent microscope with an attached CCD camera.
NEIL1 glycosylase activity assay
The 54-mer duplex DNA substrate containing Tg
(listed in Table S1 in the supplementary data) for
hNEIL1 was a gift from Dr Susan Wallace at the
University of Vermont. The strand containing Tg was
labeled at the 50 end with [g-
32P]ATP by polynucleotide
kinase and then was annealed with the other strand as
described by Lu et al. (47). The hNEIL1 reaction (10ml)
contained 2.5mM HEPES (pH 7.8), 1mM DTT, 2.5%
Glycerol, 50mM KCl, 50mg/ml bovine serum albumin,
0.5mM EDTA and 1.8 fmol of DNA substrate. The
hHus1 or 9-1-1 complex was added immediately after
hNEIL1 and reactions proceeded at 378C for 30min.
About 5ml of formamide dye (90% formamide, 10mM
MEDTA, 0.1% xylene cyanol, and 0.1% bromophenol
blue) was added to the sample, which was heated at 908C
for 3min and 7ml of the mixture was loaded onto a 14%
polyacrylamide sequencing gel containing 7M urea. The
gel images were viewed on a PhosphorImager and
quantiﬁed using the ImageQuant software (Molecular
Dynamics). The area at the product position in the no
protein control lane was used to subtract out the back-
ground signal. The hNEIL1 cleavage activity was calcu-
lated by the percentage of product over total DNA
(product plus intact bands).
RESULTS
The human 9-1-1 complex interacts withhNEIL1
We have shown that the Rad9/Rad1/Hus1heterotrimer
interacts with MYH in S. pombe and human cells (35,36).
To determine whether the 9-1-1 complex interacts with
other DNA glycosylases, we tested hNEIL1 because it is
also involved in repairing DNA lesions derived from
oxidative damage. We used the GST pull-down assay to
show the physical interactions of hNEIL1 with hRad9,
hHus1 and hRad1. GST-hHus1, GST-hRad1, or GST-
hRad9 fusion protein bound to glutathione-Sepharose was
incubated with puriﬁed hNEIL1 protein (residues 2–390).
As shown in Figure 1A, hNEIL1 could be pulled down
by GST-hHus1, GST-hRad1 and GST-hRad9. As a
negative control, hNEIL1 did not bind to GST alone
(lane 5). In reciprocal experiments, GST-hNEIL1
fusion protein bound to glutathione-Sepharose could
pull down hRad9, hRad1 and hHus1 expressed in the
baculovirus-transfected insect cells (Figure 1B). Both
phosphorylated and un-phosphorylated hRad9 interact
with hNEIL1 (Figure 1B, lane 2). Thus, hNEIL1 binds to
all three subunits of the 9-1-1 complex. The individual
proteins used in Figure 1A, B were expressed separately in
E. coli or insect cells, thus hNEIL1 can interact with
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In addition, we also incubated immobilized GST-hNEIL1
fusion protein with the partially puriﬁed 9-1-1
complex expressed in E. coli. All three subunits of the
9-1-1 complex could be pulled down by GST-hNEIL1
(Figure 1C, lane 2). In addition, the physical interaction
between hNEIL1 and hHus1 was demonstrated by
Ni-aﬃnity binding. His-tagged hHus1 bound to
Ni-beads could pull down hNEIL1 (Figure 2B, lane 1).
Finally, Far-western analysis also conﬁrmed the interac-
tion of hNEIL1 and hHus1 (Figure 2C, lane 1).
The interaction between hNEIL1 and the 9-1-1 complex
was also demonstrated by co-immunoprecipitation. We
used FLAG antibody to co-immunoprecipitate hRad9
from extracts derived from HeLa S3 cells being transfected
with pFLAG-hNEIL1 plasmid. As shown in Figure 1D
(lane 2), hRad9 could be immunoprecipitated by
FLAG antibody using extracts derived from HeLa cells
expressing FLAG-tagged hNEIL1.
Mapping the9-1-1 interacting domain within hNEIL1
By using truncated hNEIL1 proteins, we determined the
region of hNEIL1 engaged in the physical interaction with
the 9-1-1 complex. The results are shown in Figure 2A–C
and summarized in Figure 2D. In Figure 2A, immobilized
GST-hHus1, GST-hRad1 and GST-hRad9 proteins were
incubated with 100ng each of processed intact hNEIL1
(residues 2–390), C40 (residues 2–350), and C101
(residues 2–289). The hNEIL-C40 construct retained
interactions with hHus1, hRad1 and hRad9; however, the
C101 construct exhibited no interaction with the 9-1-1
complex. Ni aﬃnity binding (Figure 2B) and Far-western
analysis (Figure 2C) also conﬁrmed that any subunits of
the 9-1-1 complex could interact with C40 but not with
the C101 construct. Thus, residues 290–350 of hNEIL1
are essential for the interaction of hNEIL1 with the 9-1-1
complex.
Figure 1. Physical interaction between hNEIL1 and the 9-1-1 complex.
(A) hNEIL1 binds to all subunits of the 9-1-1 complex. GST-hHus1
(lane 2), GST-hRad1 (lane 3), GST-hRad9 (lane 4), and GST alone
(lane 5) were immobilized on glutathione-sepharose and incubated with
puriﬁed hNEIL1 (residues 2–390, 100ng). The pellets were fractionated
by a 12% SDS-PAGE followed by western blot analysis with the
hNEIL1 antibody. Lane 1 contains 30ng (30% of the total input) of
hNEIL1. (B) Binding of hRad9, hRad1 and hHus1 to GST-hNEIL1.
GST-tagged NEIL1 containing residues 1–390 (lanes 2, 5 and 8) or
GST beads (lanes 3, 6 and 9) were incubated with FLAG-tagged
hRad9, hRad1, or hHus1 ( 300ng) expressed in insect cells. The pellets
were fractionated by a 12% SDS-PAGE followed by western blot
analysis with the FLAG antibody. Lanes 1, 4 and 7 contain 10ng (10%
of the total input) of hRad9, hRad1 and hHus1, respectively. The slow-
migrating band of Rad9 is phosphorylated. (C) Binding of the 9-1-1
complex to GST-hNEIL1. GST-tagged NEIL1 containing residues
1–390 (lane 2) or GST beads (lane 3) were incubated with the partially
puriﬁed 9-1-1 complex (300ng) expressed in E. coli. The hHus1, hRad1,
and hRad9 proteins were tagged with a C-terminal His, N-terminal His,
and C-terminal S-tag, respectively. Lane 1 contains 90ng (30% of the
total input) of the partially puriﬁed 9-1-1 complex. The western blot
was detected by a mixture of the antibodies against His-tag and S-tag.
(D) Coimmunoprecipitation of hRad9 with FLAG-tagged hNEIL1
containing residues 1–390. HeLa cells were transiently transfected with
pFLAG-NEIL1. Immunoprecipation was performed with antibody
against FLAG and the western blot was detected by the antibody
against hRad9 (Imegenex) (lane 2). Lane 1 is a negative control in
which the immunoprecipation was performed with antibody against
His-tag.
Figure 2. Determination of regions within hNEIL1 involved in binding
to the 9-1-1 complex. (A) Binding of hNEIL1 deletion mutants to GST-
hRad9, GST-hRad1 and GST-Hus1. Immobilized GST-hHus1 (lane 2),
GST-hRad1 (lane 3), GST-hRad9 (lane 4), and GST alone (lane 5)
were incubated with a mixture of 100ng each of puriﬁed processed
intact hNEIL1 (residues 2–390), hNEIL1-C40 (residues 2–350) and
hNEIL1-C101 (residues 2–289). The pellets were fractionated on a
10% SDS–PAGE followed by western blot analysis with the hNEIL1
antibody. Lane 1 contains 30ng each of hNEIL1, hNEIL1-C40, and
hNEIL1-C101 (30% of the total input). (B) Binding of hNEIL1
deletion mutants to His-tagged hHus1. His-hHus1 bound to His-Select
(Sigma) magnetic beads (lanes 1–3) or Beads alone (lanes 4–6) were
incubated with wild-type or mutant hNEIL1. The presence of hNEIL1
in the pellet was examined by western analysis with anti-NEIL1
antibody. (C) Far-western analysis. Processed intact and mutant
hNEIL1 were separated by 10% SDS–PAGE and transferred onto
nitrocellulose membrane. Lane 4 contains BSA. The proteins on
the membrane were renatured and incubated with 10 pmol/ml of
His-tagged hHus1. Subsequent western blotting was performed using
His-tag antibody. (D) Graphic depiction of hNEIL1 constructs and the
summary of binding results of these constructs with the 9-1-1 complex
from Figure 2A–C. The intact hNEIL1 contains 390 amino acid
residues, however, processed intact hNEIL1 contains residues 2–390.
hNEIL1-C40 and hNEIL1-C101 contain residues 2–350 and 2–289,
respectively. The ‘þ’ and ‘ ’ listed on the right of each construct
indicate positive and negative interactions with the 9-1-1 complex,
respectively.
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Next, we tested whether hNEIL1 and hRad9 translocate
to the same nuclear foci following H2O2 treatment, by
immunoﬂuorescent staining analyses. FLAG-hNEIL1
appeared granulated in faint spots throughout the nucleus
of untreated HeLa cells expressing FLAG-hNEIL1
(Figure 3B). Human Rad9 protein molecules, as detected
by polyclonal antibodies of Rad9 from Stratagene, were
distributed to both nucleus and cytoplasm in untreated
cells (Figure 3C). Inside the nucleus, a few sites of co-
localization of hRad9 and hNEIL1 were observed in
control cells (Figure 3D). In H2O2-treated cells, hNEIL1
and hRad9 formed discrete nuclear foci (Figure 3F
and G). The majority of the hNEIL1 nuclear foci were
found to co-localize with hRad9 foci in H2O2-treated cells
(Figure 3H). This data indicates that hNEIL1 and
the 9-1-1 complex translocate to repair foci following
DNA damage.
The hNEIL1 activity can be enhanced by hHus1,hRad1,
hRad9 andthe 9-1-1 complex
The above results show that hNEIL1 physically interacts
with hHus1, hRad1, and hRad9 as individual proteins and
as a complex. We then tested whether the glycosylase and
b/d-elimination activities of hNEIL1 can be enhanced by
hHus1, hRad1, hRad9, or the 9-1-1 complex. We puriﬁed
hHus1 expressed in E. coli as well as puriﬁed hHus1,
hRad1, hRad9 and the 9-1-1 complex expressed in the
baculovirus-transfected insect cells (Figure 4). We added
increasing amounts of puriﬁed hHus1, hRad1, hRad9 and
the 9-1-1 complex to the hNEIL1 glycosylase reactions
containing the Tg substrate. As shown in Figure 5A (lanes
3–7), the strand cleavage activity of hNEIL1 by its
combined glycosylase and b/d-elimination actions was
enhanced signiﬁcantly by hHus1 protein expressed in
bacteria. The diﬀerence between hNEIL1 (1nM) alone
and hNEIL1 with 20nM of hHus1 was  5-fold (Figure
5B, diamons). Human Hus1 alone at 50nM did not
have glycosylase activity on the substrate containing Tg
(data not shown). A similar stimulation eﬀect on the
hNEIL1 strand cleavage activity was observed separately
with hHus1, hRad1, hRad9, and the 9-1-1 complex
expressed in the baculovirus system (Figure 6A–D, lanes
1–6). Interestingly, hHus1, hRad1, hRad9, separately or in
the 9-1-1 complex stimulated hNEIL1 activity to a similar
extent (Figure 7A–D, diamonds).
Figure 3. Co-localization of hNEIL1 with hRad9 following oxidative
stress. HeLa cells were transiently transfected with pFLAG-hNEIL1.
About 24h after transfection, cells were treated with 5mM H2O2 for
40min and then allowed to recover for 6h (E–H). Control cells were
not treated with H2O2 (A–D). The cells were stained with antibody
against FLAG (Sigma) (green, B and F) and anti-hRad9 antibody
(Stratagene) (red, C and G). (A) and (E) are the DAPI-stained nuclei.
(D) is the merged images of (B) and (C). (H) is the merged images of
(F) and (G). Co-localization of hNEIL1 (green) and hRad9 (red) is
visualized as yellow.
Figure 4. SDS–PAGE of puriﬁed human Hus1, Rad9, Rad1 and the 9-
1-1 complex. Lane 1, puriﬁed His-tagged hHus1 expressed in E. coli.
Lanes 2–4, FLAG-tagged hHus1, hRad1, and hRad9 were individually
expressed in insect cells and puriﬁed by FLAG-antibody (M2) aﬃnity
column. Lane 5, the 9-1-1 complex was expressed in insect cells with
three types of baculovirueses; and puriﬁed by M2 aﬃnity column and a
gel ﬁltration column (Superose 12). The slow-migrating band of Rad9
is phosphorylated (hRad9-P). Proteins were stained by Coomassie Blue.
Figure 5. hNEIL1 activity was stimulated by hHus1 expressed in
bacteria. (A) Human Hus1 enhances the activities of processed full-
length hNEIL1 containing residues 2-390. Lane 1, thymine glycol (Tg)/
A-containing DNA substrate. Lane 2, 1.8fmol (90pM) of DNA
substrate was incubated with hNEIL1 (1nM). Lanes 3–7 are similar to
lane 2 but with added 3.125, 6.25, 12.5, 25 and 50nM hHus1,
respectively. The products were separated on a 14% DNA sequencing
gel. Arrows mark the intact DNA substrate (I) and the bd-elimination
product (d). (B) Quantitative analyses of fold stimulation of hHus1 on
processed full-length hNEIL1 (diamonds), NEIL1-C40 (squares), and
NEIL1-C101 (triangles) activities from three experiments. The error
bars reported are the standard deviations of the averages.
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and C101, retained the strand cleavage activity on
DNA substrates containing Tg as the intact protein
(Figure 6A–D, lanes 2, 8, 14). Quantization of several
assays indicated  8% of the DNA substrate were cleaved
by intact, C40 and C101 hNEIL1 proteins. Thus,
the hHus1 interaction region (residues 290–350) of
hNEIL1 (Figure 2) is not essential for the hNEIL1
activity. The strand cleavage activity of C40 could be
enhanced by hHus1, hRad1, hRad9 and the 9-1-1 complex
(Figure 6A–D, lanes 8–13; and Figures 5B, 7A–D,
squares). However, hHus1, hRad1, hRad9 and the
9-1-1 complex could not enhance the activity of C101
(Figure 6A–D, lanes 14–19; and Figures 5B, 7A–D,
triangles). Thus, the 9-1-1 complex enhances the
hNEIL1 activity through direct physical interaction.
DISCUSSION
Oxidative DNA base damage is repaired mainly by
the BER pathway. It has been suggested that the
BER pathway involves highly coordinated processes
governed by protein–protein and protein–DNA interac-
tions (48–51). In this study, we show that all three subunits
of the 9-1-1 complex individually interact with hNEIL1.
The strand cleavage activity of hNEIL1 is stimulated by
hHus1, hRad1, hRad9, separately and the 9-1-1 complex
with similar degrees (Figure 7). The 9-1-1 complex is likely
not dissociated in the hNEIL1 reaction because it eluted as
one single peak from the gel ﬁltration column and it
migrated as one single band on the native gel. Thus, the
formation of the 9-1-1 complex is not a prerequisite for
hNEIL1 stimulation. Because the functional interaction is
parallel with the physical interaction between hNEIL1 and
the 9-1-1 complex, the 9-1-1 complex stimulates hNEIL1
by direct contact with hNEIL1. Recently, the 9-1-1
complex has been shown to interact with and stimulate
the enzymes involved in BER including MYH (35,36),
Polb (37), FEN1 (38,39), and DNA ligase l (40,41). Thus,
the 9-1-1 complex is not only a DNA damage sensor (18)
but is also involved in the hNEIL1-dependent BER
pathway.
In eukaryotes, there are two major subpathways
for BER: a single-nucleotide short patch and a 2-10
nucleotide long patch pathway (2,52–54). The short patch
BER pathway is usually independent of PCNA and
requires ﬁve proteins: a glycosylase, APE1, Polb and
DNA ligase III/XRCC1 heterodimer (55). The long patch
BER pathway requires a glycosylase, APE1, replication
factor C (RFC), FEN1, DNA polymerases d/e (Pold/e) (or
Polb), RPA, and DNA ligase I (54,56). Because the 9-1-1
complex can interact with DNA ligase I but not DNA
ligase III (40), it has been suggested that it may mainly be
involved in the long-patch BER. Earlier studies suggested
that the hNEIL1-dependent BER is of the short-patch
type (57). The 9-1-1 complex may also be a component of
the short-patch BER such as the hNEIL1-dependent
pathway because of its interaction with DNA polymerase
b and DNA ligase III/XRCC1 heterodimer (57). The
hNEIL1-dependent BER pathway is unique for its
independence of APE1 and interactions with polynucleo-
tide kinase and DNA ligase III/XRCC1 (57).
We have shown that the 9-1-1 complex physically and
functionally interacts with MYH in S. pombe and human
cells (35,36). Human NEIL1 is the second glycosylase to
be identiﬁed to interact with the 9-1-1 complex. Both
glycosylases reduce mutagenesis induced by oxidative
damage. NEIL1 mainly acts on oxidized pyrimidines
while MYH removes adenines or 2-hydroxyadenine
misincorporated opposite G or 7,8-dihydro-8-oxo-guanine
(8-oxoG) (58–60). The reaction mechanism of NEIL1 is
distinct from MYH. MYH is a monofunctional glyco-
sylase, whereas NEIL1 is a bifunctional glycosylase with
Figure 6. hNEIL1 activity was stimulated by hHus1, hRad1, hRad9
and the 9-1-1 complex expressed in the baculovirus-transfected
insect cells. Human Hus1 (A), hRad1 (B), hRad9 (C) and the 9-1-1
complex (D) enhance the activities of processed full-length hNEIL1 and
NEIL1-C40, but not NEIL1-C101. (A)–(D), Lane 1, thymine glycol
(Tg)/A-containing DNA substrate and lane 2, 1.8fmol (90pM) of
DNA substrate was incubated with hNEIL1 (1nM). (A)–(C), Lanes 3–7
are similar to lane 2 but with added 3.125, 6.25, 12.5, 25 and 50nM
hHus1, hRad1, or hRad9, respectively. (D), Lanes 3–7 are similar to
lane 2 but with added 4, 8, 16, 32 and 64nM of the 9-1-1 complex,
respectively. Lanes 8–13 are similar to lanes 2–7 except using 1nM
hNEIL1-C40. Lanes 14–19 are similar to lanes 2–7 except using
1nM hNEIL1-C101. The products were separated on a 14%
DNA sequencing gel. Arrows mark the intact DNA substrate (I) and
the bd-elimination product (d).
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activities can be stimulated by Hus1 and the 9-1-1
complex. Unlike MYH, which interacts with the 9-1-1
complex mainly via the Hus1 subunit (35,36), hNEIL1
interacts with hHus1, hRad1, and hRad9 equally. In
addition, both hMYH and hNEIL1 co-localize with
hRad9 following H2O2 treatment. NEIL1 expression has
been shown to be induced by ROS (61), however, MYH
expression level remains almost the same after ionizing
radiation and hydrogen peroxide treatments (35,36).
Our mapping analyses indicate that the 9-1-1 complex
interacting domain is localized to residues 290–350 of
hNEIL1. A consensus PCNA binding motif [QXX(L/
V)XXF(F/Y)] is found in many proteins involved in DNA
replication, DNA repair, DNA methylation, and chroma-
tin assembly (62,63). Recently the list of proteins that
interact with 9-1-1 has been expanding. The interacting
regions of hMYH and S. pombe MYH have been mapped
to speciﬁc motifs (36). An alignment of residues 290–350
of hNEIL1 with residues 295–350 of hMYH (Figure 8)
reveals some conserved features. Particularly, V311 of
hNEIL1 is conserved to V315 of hMYH that has been
shown to be important for the interaction between hMYH
and hHus1 (36). The crystal structure of hNEIL1
containing residues 2–342 has been determined (64).
However, there is no identiﬁable density beyond residues
290. Thus, the region containing residues 290–350 of
hNEIL1 is likely ﬂexible. It is possible that this region
becomes structured in the presence of the 9-1-1 complex
and then this conformational change promotes the
catalytic activity of hNEIL1.
It is interesting to note that residues 290–350 of hNEIL1
are also important for its interactions with Polb (57),
DNA ligase III (57), XRCC1 (57), and PCNA (Hong
Dou, Corey Theriot and Sankar Mitra, unpublished data).
How so many partner proteins interact with hNEIL1
within this common 61-residue region is unclear.
Our preliminary data suggest that PCNA at equimolar
levels slightly reduces the physical interaction between
hNEIL1 and hHus1. Because the structure of the 9-1-1
complex resembles that of PCNA sliding clamp (19–21), it
has been proposed that the 9-1-1 complex acts as a
damage-speciﬁc substitute for PCNA (38,39). The 9-1-1
complex may replace PCNA when active PCNA is
depleted by p21 during cell cycle arrest in response to
DNA damage (65). It will be interesting to ﬁnd the
mechanism by which hNEIL1 switches its partners from
PCNA to the 9-1-1 complex.
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